Inhibitory effect of furosemide on carbonic anhydrase

Tsinghua Science and Technology

Volumn 11, Issue 4, 2006, Pages 391-394

  Cui, Jianli ^a   Zhao, Tongjin ^a   Jiang, Yan ^a   Zhou, Haimeng ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Acetazolamide; Carbonic anhydrase; Furosemide; Inhibition

Indexed keywords

ACTIVATION ANALYSIS; ENZYME KINETICS; MOLECULAR STRUCTURE;

ACETAZOLAMIDE; CARBONIC ANHYDRASE; FUROSEMIDE; INHIBITION;

ENZYME INHIBITION;

EID: 33749874177     PISSN: 10070214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1007-0214(06)70206-1     Document Type: Article

References (19)

1. Tashian R E, Douglas D P, Yu Y L. Esterase and hydrase activity of carbonic anhydrase-I from primate erythrocytes. Biochem. Biophys. Res. Commun., 1964, 14(3): 256-261.
2. Pocker Y, Stone J T. The catalytic versatility of erythrocyte carbonic anhydrase III. Kinetic studies of the enzyme-catalyzed hydrolysis of p-nitrophenyl acetate. Biochemistry, 1967, 6: 668-678.
3. Jacob A V, Svchinta M, John T E. Esterase activities of human carbonic anhydrases B and C. J. Biol. Chem., 1967, 242: 4221-4229.
4. Thoms S, Pahlow M, Wolf-Gladrow D A. Model of the carbon concentrating mechanism in chloroplasts of eukaryotic algae. J. Theor. Biol., 2001, 208: 295-313.
5. Degens E T. Molecular mechanisms on carbonate, phosphate, and silica deposition in the living cell. Topics Curr. Chem., 1976, 64: 1-112.
6. Khanna A, Kurtzman N A. Metabolic alkalosis. Respir. Care, 2001, 46: 354-365.
7. - movements in salivary acinar cells. J. Gen. Physiol., 2004, 124: 59-69.
8. Goldfarb D S, Chan A J, Hernandez D, Charney A N. Effects of thiazides on colonic NaCl absorption: Role of carbonic anhydrase. Am. J. Physiol., 1991, 261: F452-F458.
9. Hewett E D, Tashian R E. Functional diversity, conservation, and convergence in the evolution of α-, β-, and γ-carbonic anhydrase gene families. Mol. Phylogener. Evol., 1996, 5: 50-77.
10. Thomas A D, Joseph E C. Macaca mulata carbonic anhydrase. Crystallization and physicochemical and enzymatic properties of two isozymes. Biochemistry, 1966, 5: 2009-2019.
11. Odlind B. Site and mechanism of the action of diuretics. Acta Pharmacol. Toxicol. (Copenhagen), 1984, 54(S1): 5-15.
12. Yano I, Takayama A, Takano M, Inatani M, Tanihara H, Ogura Y, Honda Y, Inui K. Pharmacokinetics and pharmacodynamics of acetazolamide in patients with transient intraocular pressure elevation. Eur. J. Clin. Pharmacol., 1998, 54: 63-68.
13. Haas M. The Na-K-Cl cotransporters. Am. J. Physiol., 1994, 267: C869-C885.
14. Ferrari P, Frey F J. Pharmacologic action of diuretics in the kidney. Ther.Umsch., 2000, 57: 345-350.
15. Khadikar P V, Sharma V, Karmarkar S, Supurcan C T. Novel use of chemical shift in NMR as molecular descriptor: A first report on modeling carbonic anhydrase inhibitory activity and related parameters. Bioorg. Med. Chem. Lett., 2005, 15: 931-936.
16. Supuran C T, Casini A, Mastrolorenzo A, Scozzafava A. COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents. Mini Reviews in Medicinal Chemistry, 2004, 4: 625-632.
17. Puscas I, Coltau M, Baican M, Pasca R, Domuta G. The inhibitory effect of diuretics on carbonic anhydrases. Res. Commun. Mol. Pathol. Pharmacol., 1999, 105: 213-236.
18. Lindskog S. Structure and mechanism of carbonic anhydrase. Pharmacol. Ther., 1997, 74: 1-20.
19. Casini A, Scozzafava A, Mastrolorenzo A, Supuran C T. Sulfonamides and sulfonylated derivatives as anticancer agents. Curr. Cancer Drug Targets, 2002, 2: 55-75.